Article

Visual impairment due to cataract affects mostly patients in poverty, according to study

People with cataract-induced visual impairment are more likely to live in poverty than those with normal sight, according to a study conducted in three developing countries-Kenya, the Philippines, and Bangladesh.

London-People with cataract-induced visual impairment are more likely to live in poverty than those with normal sight, according to a study conducted in three developing countries-Kenya, the Philippines, and Bangladesh.

Cataract is the cause of more than one-third of the world’s 45 million people affected by blindness. The treatment is relatively inexpensive and simple, but some evidence suggests that lack of money is a major barrier to have cataract surgery by individuals in poor countries.

The study looked at 596 people aged 50 years or more with severe cataract-induced visual impairment, matching each case with a normally sighted person of similar age and sex living nearby. The measure of poverty was by monthly per capita expenditure (PCE), self-rated wealth, and ownership of assets.

For all three countries, the cases were more likely than controls to be in the lowest quarter of the range of PCEs for that country. Risk of cataract-related visual impairment increased as PCE decreased in all three countries. No consistent association existed, however, between PCE and the level of cataract-induced visual impairment.

"This study confirms an association between poverty and blindness and highlights the need for increased provision of cataract surgery to poor people, particularly since cataract surgery is a highly cost-effective intervention in these settings," said the authors from the International Centre for Eye Health, London School of Hygiene and Tropical Medicine.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.